Naturally processed tissue- and differentiation stage-specific autologous peptides bound by HLA class I and II molecules of chronic myeloid leukemia blasts

Blood

Volumn 90, Issue 12, 1997, Pages 4938-4946

  Papadopoulos, Kyriakos P ^a   Suciu Foca, Nicole ^a   Hesdorffer, Charles S ^a   Tugulea, Sorina ^a   Maffei, Antonella ^a   Harris, Paul E ^a  

^a P and S 14 401 ^*

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; BCR ABL PROTEIN; CATHEPSIN G; CD34 ANTIGEN; COLONY STIMULATING FACTOR RECEPTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; MESSENGER RNA; MONOCLONAL ANTIBODY; PEPTIDE; PROTEINASE;

ANTIGEN PRESENTATION; ARTICLE; BLAST CELL; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TISSUE SPECIFICITY;

EID: 0031442008     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.12.4938     Document Type: Article

References (51)

1. Rowley J: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290, 1973
2. Melo J: The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 88:2375, 1996
3. Bocchia M, Korontsvit T, Xu Q, Mackinnon S, Yang SY, Sette A, Scheinberg DA: Specific human cellular immunity to bcr-abl oncogene-derived peptides. Blood 87:3587, 1996
4. Cullis JO, Barrett AJ, Goldman JM, Lechler RI: Binding of BCR/ABL junctional peptides to major histocompatibility complex (MHC) class I molecules: Studies in antigen-processing defective cell lines. Leukemia 8:165, 1994
5. ten Bosch GJ, Toornvliet AC, Friede T, Melief CJ, Leeksma OC: Recognition of peptides corresponding to the joining region of p210BCR-ABL protein by human T cells. Leukemia 9:1344, 1995
6. Wetzler M, Talpaz M, Van Etten RA, Hirsh-Ginsberg C, Beran M, Kurzrock R: Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation. J Clin Invest 92:1925, 1993
7. + T cells elicited by primary in vitro immunization with a BCR-ABL breakpoint peptide. Blood 88:3522, 1996
8. Sant AJ: Endogenous antigen presentation by MHC class II molecules. Immunol Res 13:253, 1994
9. Bocchia M, Wentworth PA, Southwood S, Sidney J, McGraw K, Scheinberg DA, Sette A: Specific binding of leukemia oncogene fusion protein peptides to HLA class I molecules. Blood 85:2680, 1995
10. Greco G, Fruci D, Accapezzato D, Barnaba V, Nisini R, Alimena G, Montefusco E, Vigneti E, Butler R, Tanigaki N, Tosi R: Two brc-abl junction peptides bind HLA-A3 molecules and allow specific induction of human cytotoxic T lymphocytes. Leukemia 10:693, 1996
11. Martinelli G, Zaccaria A, Saglio G, Zuffa E, Farabegoli P, Testoni N, Conte R, Tura S: Binding of BCR/ABL junctional peptides to major histocompatibility complex (MHC) class I-B35 molecules: Relationship between antigen defective cell lines and HLA frequencies in CML patients. Leukemia 9:1795, 1995
12. Nanda N, Sercarz E: Induction of anti-self-immunity to cure cancer. Cell 82:13, 1995
13. Brichard V, Van Pel A, Wolfel T, Wolfel C, De Plaen E, Lethe B, Coulie P, Boon T: The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 178:489, 1993
14. Cheever MA, Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, Qin HL, Takahashi M, Chen W: Immunity to oncogenic proteins. Immunol Rev 145:33, 1995
15. Molldrem J, Dermime S, Parker K, Jiang Y, Mavroudis D, Hensel N, Fukushima P, Barrett J: Targeted T-cell therapy for human leukemia: Cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells. Blood 88:2450, 1996
16. Harris PE, Lupu F, Hong B, Reed EF, Suciu-Foca N: Differentiation-stage specific self-peptides bound by major histocompatibility complex class I molecules. J Exp Med 177:783, 1993
17. Harris PE, Maffei A, Liu Z, Colovai I, Reed EF, Inghirami G, Suciu-Foca N: Naturally processed cytokine-derived peptide bound to HLA-class II molecules. J Immunol 151:5975, 1993
18. Chirgwin JM, Przybyla AE, MacDonald RJ, Rutter WJ: Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18:5294, 1979
19. Harris PE: Self-peptides bound to HLA molecules. Crit Rev Immunol 14:61, 1994
20. Hill CM, Hayball JD, Allison AA, Rothbard JB: Conformational and structural characteristics of peptides binding to HLA-DR molecules. J Immunol 147:189, 1991
21. Collins S, Coleman H, Groudine M: Expression of bcr and bcr-abl fusion transcripts in normal and leukemic cells. Mol Cell Biol 7:2870, 1987
22. Blake TJ, Shapiro M, Morse HCd, Langdon WY: The sequences of the human and mouse c-cbl proto-oncogenes show v-cbl was generated by a large truncation encompassing a proline-rich domain and a leucine zipper-like motif. Oncogene 6:653, 1991
23. Grove JR, Banerjee P, Balasubramanyam A, Coffer PJ, Price DJ, Avruch J, Woodgett JR: Cloning and expression of two human p70 S6 kinase polypeptides differing only at their amino termini. Mol Cell Biol 11:5541, 1991
24. Parker KC, Bednarek MA, Coligan JE: Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152:163, 1994
25. Hohn PA, Popescu NC, Hanson RD, Salvesen G, Ley TJ: Genomic organization and chromosomal localization of the human cathepsin G gene. J Biol Chem 264:13412, 1989
26. Campanelli D, Melchior M, Fu Y, Nakata M, Shuman H, Nathan C, Gabay JE: Cloning of cDNA for proteinase 3: A serine protease, antibiotic, and autoantigen from human neutrophils. J Exp Med 172:1709, 1990
27. Miller JS, Moxley G, Schwartz LB: Cloning and characterization of a second complementary DNA for human tryptase. J Clin Invest 86:864, 1990
28. Hirata RK, Chen ST, Weil SC: Expression of granule protein mRNAs in acute promyelocytic leukemia. Hematol Pathol 7:225, 1993
29. Amson R, Sigaux F, Przedborski S, Flandrin G, Givol D, Telerman A: The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proc Natl Acad Sci USA 86:8857, 1989
30. Care A, Mattia G, Montesoro E, Parolini I, Russo G, Colombo MP, Peschle C: c-fes expression in ontogenetic development and hematopoietic differentiation. Oncogene 9:739, 1994
31. Greer P, Haigh J, Mbamalu G, Khoo W, Bernstein A, Pawson T: The Fps/Fes protein-tyrosine kinase promotes angiogenesis in transgenic mice. Mol Cell Biol 14:6755, 1994
32. Miyajima A, Mui AL, Ogorochi T, Sakamaki K: Receptors for granulocyte-macrophage colony-stimulating factor, interleukin-3, and interleukin-5. Blood 82:1960, 1993
33. Goebeler M, Roth J, van den Bos C, Ader G, Sorg C: Increase of calcium levels in epithelial cells induces translocation of calciumbinding proteins migration inhibitory factor-related protein 8 (MRP8) and MRP14 to keratin intermediate filaments. Biochem J 309:419, 1995
34. Kikuta Y, Kusunose E, Endo K, Yamamoto S, Sogawa K, Fujii-Kuriyama Y, Kusunose M: A novel form of cytochrome P-450 family 4 in human polymorphonuclear leukocytes. cDNA cloning and expression of leukotriene B4 omega-hydroxylase. J Biol Chem 268:9376, 1993
35. Harris PE, Maffei A, Colovai AI, Kinne J, Tugulea S, Suciu-Foca N: Predominant HLA-class II bound self-peptides of a hematopoietic progenitor cell line are derived from intracellular proteins. Blood 87:5104, 1996
36. Harris P, Colovai A, Maffei A, Liu Z, Suciu-Foca N: MHC class I presentation of exogenous and endogenous protein derived peptides by a transfected human monocyte cell line. Immunology 86:606, 1995
37. Gueguen M, Long EO: Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen. Proc Natl Acad Sci USA 93:14692, 1996
38. Akashi K, Mizuno S, Harada M, Kimura N, Kinjyo M, Shibuya T, Shimoda K, Takeshita M, Okamura S, Matsumoto I, Kikuchi M, Neho Y: T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia. Exp Hematol 21:743, 1993
39. Diamond J, Goldman JM, Melo JV: BCR-ABL, ABL-BCR, BCR, and ABL genes are all expressed in individual granulocyte-macrophage colony-forming unit colonies derived from blood of patients with chronic myeloid leukemia. Blood 85:2171, 1995
40. Townsend A, Bastin J, Gould K, Brownlee G, Andrew M, Coupar B, Boyle D, Chan S, Smith G: Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med 168:1211, 1988
41. Buzyn-Veil A, Ostankovitch M, Zerbib A, Connan F, Vanet B, Guillet J-G, Choppin J: Peptides derived from the whole sequence of bcr-abl promote very efficiently assembly of 8 different HLA class I molecules and can prime a specific T cell cytotoxic response. Bone Marrow Transplant 19:S92, 1997 (abstr)
42. Smithgall TE, Johnston JB, Bustin M, Glazer RI: Elevated expression of the c-fes proto-oncogene in adult human myeloid leukemia cells in the absence of gene amplification, J Natl Cancer Inst 83:42, 1991
43. Maru Y, Peters KL, Afar DE, Shibuya M, Witte ON, Smithgall TE: Tyrosine phosphorylation of BCR by FPS/FES protein-tyrosine kinases induces association of BCR with GRB-2/SOS. Mol Cell Biol 15:835, 1995
44. Salgia R, Sattler M, Pisick E, Li JL, Griffin JD: p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p 120c-Cb1. Exp Hematol 24:310, 1996
45. Wang Y, Yeung YG, Langdon WY, Stanley ER: c-Cb1 is transiently tyrosine-phosphorylated, ubiquitinated, and membrane-targeted following CSF-1 stimulation of macrophages. J Biol Chem 271:17, 1996
46. Hochstrasser M: Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol 7:215, 1995
47. Shaeffer JR, Kania MA: Degradation of monoubiquitinated alpha-globin by 26S proteasomes. Biochemistry 34:4015, 1995
48. Hou D, Cenciarelli C, Jensen JP, Nguygen HB, Weissman AM: Activation-dependent ubiquitination of a T cell antigen receptor subunit on multiple intracellular lysines. J Biol Chem 269:14244, 1994
49. Isaksson A, Musti AM, Bohmann D: Ubiquitin in signal transduction and cell transformation. Biochem Biophys Acta 1288:F21, 1996
50. Grisolano JL, Sclar GM, Ley TJ: Early myeloid cell-specific expression of the human cathepsin G gene in transgenic mice. Proc Natl Acad Sci USA 91:8989, 1994
51. Sobajima J, Ozaki S, Okazaki T, Osakada F, Sumita S, Mori K, Nakao K: Anti-neutrophil cytoplasmic antibodies (ANCA) in ulcerative colitis: Anti-cathepsin G and a novel antibody correlate with a refractory type.Clin Exp Immunol 105:120, 1996